
ED Raids Coldrif Manufacturer, TNFDA Officials
ED Raids Coldrif Manufacturer, TNFDA Officials
Chennai- The ED on Monday raided premises linked to Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup linked to the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA as part of a money laundering investigation, official sources said.
At least seven premises in Chennai are being covered by the Enforcement Directorate as part of the action under the Prevention of Money Laundering Act (PMLA), they said.
At least 20 children, mostly under the age of five, have died after being administered Coldrif in Madhya Pradesh and Rajasthan.
ADVERTISEMENTLicensed in 2011 by the Tamil Nadu Food and Drug Administration (TNFDA), the Kanchipuram-based Sresan Pharma continued operations unchecked for over a decade despite its dismal infrastructure and multiple violations of national drug safety rules, the Central Drugs Standard Control Organisation (CDSCO) has said.
The cough syrup was found to be“dangerously” adulterated with diethylene glycol (DEG), a highly poisonous substance.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Pepeto Highlights $6.8M Presale Amid Ethereum's Price Moves And Opportunities
- Codego Launches Whitelabel Devices Bringing Tokens Into Daily Life
- Zeni.Ai Launches First AI-Powered Rewards Business Debit Card
- LYS Labs Moves Beyond Data And Aims To Become The Operating System For Automated Global Finance
- Whale.Io Launches Battlepass Season 3, Featuring $77,000 In Crypto Casino Rewards
- Ceffu Secures Full VASP Operating License From Dubai's VARA
Comments
No comment